Evidence of aldosterone synthesis in human myocardium in acute myocarditis.

[1]  Gerasimos S Filippatos,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of the American College of Cardiology.

[2]  S. Raman,et al.  Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial , 2017, Orphanet Journal of Rare Diseases.

[3]  G. Fonarow,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Circulation.

[4]  S. Raman,et al.  Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial , 2015, The Lancet Neurology.

[5]  K. Sliwa,et al.  The global burden of myocarditis: part 1: a systematic literature review for the Global Burden of Diseases, Injuries, and Risk Factors 2010 study. , 2014, Global heart.

[6]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[7]  M. Friedrich,et al.  Cardiac Magnetic Resonance Assessment of Myocarditis , 2013, Circulation. Cardiovascular imaging.

[8]  N. Brown.  Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis , 2013, Nature Reviews Nephrology.

[9]  A. Angelini,et al.  2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. , 2012, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[10]  Sandeep Sagar,et al.  Myocarditis , 2012, The Lancet.

[11]  L. Cooper,et al.  Update on myocarditis. , 2012, Journal of the American College of Cardiology.

[12]  S. Raman,et al.  Advances in Cardiovascular Imaging Cardiac Involvement in Patients With Muscular Dystrophies Magnetic Resonance Imaging Phenotype and Genotypic Considerations , 2011 .

[13]  Clive Lewis,et al.  The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  A. Matsumori,et al.  Anti‐inflammatory effects of eplerenone on viral myocarditis , 2009, European journal of heart failure.

[15]  A. Angelini,et al.  A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. , 2007, European heart journal.

[16]  K. Weber,et al.  Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype. , 2003, American journal of physiology. Heart and circulatory physiology.

[17]  K. Weber,et al.  Aldosteronism in heart failure: a proinflammatory/fibrogenic cardiac phenotype. Search for biomarkers and potential drug targets. , 2003, Current drug targets.

[18]  P. White.  Aldosterone: direct effects on and production by the heart. , 2003, The Journal of clinical endocrinology and metabolism.

[19]  K. Weber,et al.  Aldosterone-induced inflammation in the rat heart : role of oxidative stress. , 2002, The American journal of pathology.

[20]  Expression of aldosterone synthase gene in failing human heart: quantitative analysis using modified real-time polymerase chain reaction. , 2002, The Journal of clinical endocrinology and metabolism.

[21]  M. Young,et al.  Cardiac steroidogenesis in the normal and failing heart. , 2001, The Journal of clinical endocrinology and metabolism.

[22]  I. Miyamori,et al.  Cardiac Aldosterone Production in Genetically Hypertensive Rats , 2000, Hypertension.

[23]  P. White,et al.  Steroidogenic enzyme gene expression in the human heart. , 2000, The Journal of clinical endocrinology and metabolism.

[24]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[25]  A. Carayon,et al.  , Brigitte Angiotensin II Receptor Blockade and Role in Cardiac Fibrosis Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction : Effect of , 1999 .

[26]  C. Kawai,et al.  From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. , 1999, Circulation.

[27]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[28]  B. McManus,et al.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. , 1995, The New England journal of medicine.

[29]  畠山 治彦.  Vascular aldosterone : biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells , 1995 .

[30]  W. Edwards,et al.  Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.